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INTRODUCTION: The purpose of this study was to (1) identify the functional results after aneurysm surgery in
patients with ischemic cardiomyopathy and (2) identify predictors of favorable outcomes.
METHODS AND MATERIAL: Patients (n = 169) with angiographic left ventricular ejection fraction of 22¡5%
underwent aneurysm surgery and were prospectively followed for three years. Prior to surgery, 40% and 60% of the
patients were in congestive heart failure NYHA class I/II and III/IV, respectively. Concomitant revascularization was
performed on 95% of the patients.
RESULTS: Cumulative in-hospital and 36-month mortalities were 7% and 15%, respectively. These respective rates
varied according to preoperative parameters: CHF class I-II, 4% and 13%; CHF class III-IV, 8% and 16%; LVEF,20%,
12% and 26%; LVEF 21-30%, 2% and 6%; gated LVEF exercise/rest .5%, ,1% and 4%; and gated LVEF exercise/rest
#5%, 17% and 38%. Higher LVEF ex/rest ratio (p = 0.01), male sex (p = 0.05), and a higher number of grafts (p = 0.01)
were predictive of improvement in CHF class at follow-up based on the results of a multivariate analysis. After three
years of follow-up, 84% of the patients were in class I/II, LVEF was 45¡7%, and gated LVEF ex/rest ratio was 13%
higher (p,0.01) compared to the beginning of the study.
CONCLUSIONS: These data suggest that aneurysmectomy among patients with severe LV dysfunction result in short-
and long-term favorable functional outcome and survival. Selection of appropriate surgical candidates may
substantially improve survival rates among these patients.
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Aneurysmectomy.
Serrano Jr. CV, Ramires JAF, Soeiro AM, Ce´sar LAM, Hueb WA, Dallan LA, Jatene FB, Stolff NAG. Efficacy of aneurysmectomy in patients with severe
left ventricular dysfunction: favorable short- and long-term results in ischemic cardiomyopathy. Clinics. 2010;65(10):947-952.
Received for publication on May 10, 2010; First review completed on May 31, 2010; Accepted for publication on July 7, 2010
E-mail: alexandre.soeiro@bol.com.br
Tel.: 55 11 3067-7427
INTRODUCTION
The term ischemic cardiomyopathy (ICM) is used to
describe the clinical picture and pathological findings in
patients with congestive heart failure secondary to ischemic
heart disease. Manifestations of congestive heart failure are
common in patients with coronary artery disease. They may
be the dominant feature in those who have sustained prior
myocardial infarctions with ischemic areas replaced by
fibrous tissue, with disappearance or reduction of angina
symptoms. The three most common causes of congestive
heart failure in this setting are left ventricular aneurysm,
mitral regurgitation due to dilatation of the mitral annulus
and/or papillary muscle ischemic dysfunction, and an
inadequate quantity of normally contracting myocardium.1,2
ICM can also result from myocardial hibernation, which is
characterized as a situation of reduced regional contractile
function distal to a coronary artery stenosis from which the
individual recovers after removal of the coronary stenosis.3
Patients who have untreated infarct-related ventricular
aneurysms that compromise 20% to 25% of the left
ventricular area develop progressive global ventricular
dilatation. The rationale for congestive heart failure among
ventricular aneurysms is that the fraction of blood that
enters the region of the aneurysms causes an overload state,
and severe global dilatation of the heart ensues over time.3
The surgical treatment of left ventricular dysfunction has
evolved gradually. Initially, it was demonstrated that
patients with large ventricular aneurysms and severe
cardiac failure improved with resection of the ventricular
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aneurysm.3 Surgical therapy of ventricular aneurysms
evolved further with the intracavitary patch techniques of
Jatene,2 Dor,1 and Cooley4 that have yielded excellent
surgical and functional results. However, the clinical and
survival benefits of aneurysmectomy when severe left
ventricular dysfunction is present remained controversial
until the STICH trial in 2009, the results of which showed
no reduction in the rate of death or hospitalization for
cardiac causes in patients submitted to aneurysmectomy.5
Therefore, the objective of this study was to describe the
short- and long-term functional results after aneurysmect-
omy surgery in ICM and to identify predictors of a favorable
outcome.
METHODS AND MATERIAL
Patient population. Between June 1992 and December
1995, 169 consecutive patients with ischemic heart disease
underwent aneurysmectomy surgery at our institution. Prior
to data collection, this study was approval by the ethics
committee. Baseline clinical characteristics of patients are
shown in Table 1. The three-year follow-up period was
completed in 2001 by means of telephone contact or office
visits. Follow-up consisted of obtaining information about the
functional class of congestive heart failure (New York Heart
Association), angina (Canadian Cardiovascular Society
[CCS]), and survival data using a medical questionnaire.
Coronary angiography was conducted with all patients.
In addition, the number of diseased coronary vessels (lumen
narrowing $ 70%) was assessed. Global left ventricular
ejection fraction (LVEF) was also measured by contrasted
ventriculography. Left ventricular dysfunction was char-
acterized by an ejection fraction # 30%. Left ventricular
aneurysm was defined as a zone of paradoxical systolic
expansion (dyskinetic) or as an akinetic myocardial zone
well delimited from the surrounding cardiac silhouette.
Viability data were obtained by echocardiographic stress
test or thallium scintigraphy for all patients. Baseline
coronary angiography and ventriculography data are
shown in Table 2. The indication for surgery was left
ventricular failure, refractory to medical therapy, in the
presence of an anatomic left ventricular aneurysm and
concomitant coronary stenosis suitable for coronary artery
bypass grafting (CABG).
Operative procedures. With the patient supported on
normothermic cardiopulmonary bypass, the heart was
carefully examined to confirm the extension excise portion
of a nonfunctioning wall previously analyzed by echo-
cardiography or ventriculography. Once thinning of the
nonfunctioning area was confirmed, a small incision was
made. Any clot present was carefully removed. With the
unloaded heart opened and beating, the surrounding wall
was palpated, and its ability to contract (regional wall
thickening) was reliably assessed. All thinned nonfunction-
ing portions of the wall were considered for resection.
Excision was planned to remove as much nonfunctioning
wall as possible while restoring ventricular size and shape
toward normal conditions as described by Jatene.2 In many
cases, the excised specimen was composed of a mixture of
infarcted and viable muscle. In addition, repair sutures were
often placed through relatively thick areas of myocardium.
Sutures were positioned further apart on the tissue edges
than on the felt strips so that the length of the incision was
plicated in the closure to help to restore the shape of the
ventricle toward normal conditions.
In most patients with an anterior aneurysm, scarring of
the septum was observed. However, only in cases in which
a major portion of the septum was both scarred and thinned
was a septoplasty performed, as previously described. The
anterior edge of the patch was incorporated into the
ventricular closure. Once ventricular repair was completed,
bypass grafting was carried out when indicated. Retrograde
cardioplegia and antegrade cardioplegia or infusion down a
right graft were utilized to protect the left and right
ventricle, respectively. Complete revascularization was
performed in all patients according to the noninvasive test
performed.
In this study, a total of 290 grafts were accomplished,
providing a grafts/patient ratio of 1.8¡0.4 (see Table 3).
Nine patients with left anterior descending artery lesion did
not receive any kind of graft. Intraoperative transesophageal
echocardiography was conducted to confirm mitral insuffi-
ciency. If confirmed, both a left atriotomy and a left
ventriculotomy through the aneurysm were performed. If
the mitral valve was so severely diseased that it could not be
repaired, a prosthetic mitral valve was implanted. After
Table 1 - Baseline clinical characteristics of the study
population (n = 169).
Characteristic, n (percentage)
Men 111 (66%)
Age (in years) 61¡9 (range: 31-78)
Arterial hypertension 76 (45%)
Smokers 75 (44%)
Total cholesterol . 240 mg/dL 64 (38%)
Diabetes 59 (35%)
Months since myocardial infarction 9.4¡6.2 (range; 1.5-32)
Functional class (CHF NYHA)a
I 16 (9%)
II 53 (31%)
III 59 (35%)
IV 41 (25%)
Electrocardiographic Findings
Sinus rhythm 135 (80%)
Atrial fibrillation 84 (20%)
Left anterior divisional block 81 (48%)
Left bundle branch block 53 (31%)
First degree atrioventricular block 38 (22%)
Third degree atrioventricular block 6 (4%)
aCHF NYHA, congestive heart failure according to the New York Heart
Association.
Table 2 - Baseline angiographic data of the study
population (n = 169).
Characteristic
Lesion on left anterior descending artery (LADA)
n(%)a
Occlusion of LADA 87 (51%)
Critical stenosis of LADA (70-99%) 52 (31%)
, 70% stenosis of LADA 30 (18%)
Type of lesion n(%)b
Uniarterial lesion 51 (30%)
Biarterial lesions 62 (37%)
Triarterial lesions 56 (33%)
Left ventricular ejection mean¡SD 22¡5% (range: 11-30)
aBetween lesions on LADA: p,0.0001.
bBetween types of lesion: p = 0.58.
Note: Left ventricular ejection fraction measured by contrasted
ventriculography. Data expressed as number or percentage.
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completion of the myocardial revascularization and mitral
valve surgery, attention was directed toward the repair of
the ventricular aneurysm. Mitral repair/replacement was
done in 13 cases.
Statistical analysis. Spearman’s rank test was used for
correlations, whereas multiple regression analysis was
utilized to assess the potential associations. The cumula-
tive probability of events was determined using the Kaplan-
Meier method, and differences in the distribution of events
during the three-year study period were evaluated with the
log-rank test. A p-value # 0.05 was considered to be
statistically significant.
RESULTS
Early post-operative care. Seven (4.1%) patients died in
the hospital due to cardiac causes. Results of univariate
analyses demonstrated that angina was associated with a
decreased risk of hospital mortality (p = 0.04), whereas pro-
longed duration of cardiopulmonary bypass was associated
with an increased risk of hospital mortality (p = 0.03). When
entered into the multivariate analysis, none of the variables
examined proved to be predictive. Specific features in the
postoperative treatment in the intensive care unit are shown
in Table 4. Significant differences occurred between patients
who survived and patients who died during hospitalization.
Late clinical follow-up. Of the initial 169 patients,
contrast ventriculography (for LVEF determination) was
repeated on 133 (79%) patients at 6 months, 90 (53%)
patients at 12 months, and 75 (44%) patients at 36 months.
The initial LVEF of 22¡5% increased significantly to
40¡3% at 6 months and 45¡6% and 45¡7% at 12 and 36
months, respectively (see Figure 1). After three years of
follow-up, we had information about 83% (140) of patients
included in study. Ten (6.3%) late casualties were recorded
during the follow-up period. Actuarial survival was 91.1%,
90.5%, and 89.2% at one, two, and three years, respectively
(see Figure 2A). Actuarial survival rates based on baseline
characteristics are shown in Figures 2B, 2C, and 2D.
There was a successful functional outcome of myocardial
revascularization as evidenced by a significant improve-
ment in congestive heart failure NYHA class, gated LVEF
ex/rest ratio by radioisotopic ventriculography performed
at 2 and 36 months, and contrast ventriculography.
Congestive heart failure classes I, II, III, and IV were
observed in 81 (56%), 42 (29%), 16 (10%), and 8 (5%)
operative survivors at follow-up, respectively (see Figure 3).
Angina classes (CCS) I/II and III/IV were observed in 54%
and 16% of patients, respectively, at three-year follow-up. In
30% of patients, we did not observe angina.
Several variables were identified as correlates of recurrent
heart failure. In particular, lower LVEF, presentation with
congestive heart failure, and need for preoperative IABP
were associated with a greater likelihood of recurrent heart
failure, whereas higher LVEF ex/rest ratio (p = 0.01), male
sex (p = 0.055), and higher number of grafts (p = 0.01) were
predictive of improvement in congestive heart failure class
at follow-up.
DISCUSSION
These data suggest that, among patients with severe left
ventricular dysfunction, aneurysmectomy results in favorable
short- and long-term functional and clinical outcomes, which
lead to satisfactory survival rates. Selection of appropriate
surgical candidates and extensive use of concomitant revas-
cularization substantially improves survival rates. Currently,
aneurysmectomy is considered to be a prominent surgical
technique of left ventricular reconstruction for either dyski-
netic or akinetic left ventricular segments in patients with
ICM. Dyskinetic/akinetic left ventricular segments almost
exclusively involve the left ventricle, most commonly the
anterior or apical segments. For the detection of left
ventricular dyskinetic/akinetic segments, biplane left ventri-
culography is a precise method that is available for outlining
left ventricular segments, assessing septal motion, and
determining the quantity of functioning residual myocar-
dium.4 Nevertheless, other noninvasive methods, such as
magnetic resonance imaging, that were unavailable at the
time of the study are gaining popularity. Aneurysmectomy
associated with concomitant CABG improves ventricular
function in patients with severe coronary artery disease and
severe left ventricular dysfunction.
Table 3 - Surgical treatment.
All grafts 290
Left internal thoracic artery 132
Right internal thoracic artery 46
Radial artery 32
Safena vein 80
Grafts/ patient 1.8 ¡ 0,4
Mitral valve replacement/repair 13
Table 4 - Post-surgical in-hospital data.
Total
(n = 169)
Survived
(n = 158, 93%)
Died
(n = 11, 7%)
Intensive care unit (in days)a 16¡4 12¡3 19¡3
Hospital stay (in days)a 27¡9 15¡4 33¡5
Need of vasoactive agents,
n(%)a *
109 (64%) 98 (62%) 11 (100%)
Need of mechanical
ventilation n(%)b *
3.4¡2.1 0.8¡0.2 4.8¡0.5
Acute renal failure n(%)a 19 (11%) 8 (5%) 11 (100%)
Urinary or respiratory tract
infection n(%)c
11 (7%) 31 (20%) 8 (73%)
Between patients who survived and patients who died during
hospitalization: ap,0.0001, bp,0.01, cp = 0.001.* = more than 24 hours
after surgery. Mean¡SD.
Figure 1 - Left ventricular ejection fraction (LVEF) determined by
contrast ventriculogram.
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Functional outcome. Few clinical series have focused on
the functional outcome after myocardial revascularization in
ICM. Most researchers have verified that short- and long-
term survival rates after surgery are acceptable. The dis-
closure of short-term progress in left ventricular systolic
performance has generally been viewed as an indicator of
successful functional effect.6,7 Contrary to this hypothesis,
present evidence suggests that an increase in left ventricular
ejection fraction is not accompanied by clinical improve-
ment.6 These findings have significant implications because
clinical management of congestive heart failure has also
produced significant progress in terms of both survival and
Figure 2 - Cumulative mortality: A, global; B, according to baseline congestive heart failure New York Heart Association classification
(CHF NYHF); C, according to baseline left ventricular ejection fraction (LVEF); D, according to baseline gated left ventricular ejection
fraction (LVEF) exercise (ex)/rest ratio.
Figure 3 - Incidence of congestive heart failure after surgery according to functional class (New York Heart Association classification).
*p,0.01 vs. baseline.
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control of symptoms.7 Thus, the preference of the most
advantageous therapeutic modality for a specific patient
with ischemic left ventricular dysfunction must be well
thought out. Merely considering survival may be
inadequate to distinguish among therapeutic options.
For the most part, congestive heart failure is accountable
for the satisfactorily low occurrence of symptoms late after
surgery. Estimates of recurrent heart failure are well
described and differ broadly from other studies of patients
with ICM, ranging from 28% to 63%.7 The current findings
are consistent with those of previous studies. It is possible
that the cases of recurrent heart failure point to the
unyielding development in the direction of left ventricular
dysfunction.7 Determination of left ventricular ejection
fraction by echocardiogram is reasonable to reveal the
relationship between left ventricular systolic function and
congestive heart failure late after revascularization.
Predicting the recurrence or appearance of the symptoms of
congestive heart failure has immeasurable relevance in terms
of patient selection. The present study linked the greater
possibility of heart failure at follow-up after aneurysmectomy
with female sex, history of congestive heart failure, lower
ejection fraction, and need for preoperative IABP support. In
addition, history of angina, use of the left internal thoracic
artery, and number of bypass grafts were inversely related to
recurrence of congestive heart failure.
The importance of demographic characteristics before
surgery is quite obvious, even though a relation with
recurrent heart failure has not been previously described. In
fact, lower ejection fraction has frequently been associated
with unfavorable long-term outcomes after revasculariza-
tion in ICM, as have history of congestive heart failure and
female sex.7 The requirement for preoperative IABP may
predict which patients will have more severe left ventricular
failure. Assessment of known evidence is problematic
because not many researchers have investigated the
recurrence of congestive heart failure in large clinical trials.
Whereas the clinical variables per se have an influence on
patient selection, the operative variables examined in this
study have applicable management connotations. Evidence
suggests that more widespread exploitation of left internal
thoracic artery grafts and complete myocardial revascular-
ization can diminish the recurrence of congestive failure in
the short- and long-term following surgery. This finding is
consistent with inferences made by previous researchers
regarding the overall revascularization patients.7-20 Failure
to previously demonstrate an association on ICM between
the sort of graft for bypass and long-term coronary events
by other investigators may be related to the decreased
application of the left internal thoracic artery (i.e., between
20% and 35% when informed).7 The rationale for not
employing the left thoracic artery in the past in patients
with ICM was due to apprehension about complications
related to advanced age, urgency of revascularization, and
reserved anxiety about long-term prognosis.16 However, the
findings of this study and other recent studies16,17,19-23
suggest that there is little cause for concern. Thus, patients
with ICM should be managed with a left internal thoracic
artery graft when revascularization is selected therapy.15
Survival. Coronary artery bypass grafting has advanced
into a secure therapy approach for selected patients with
ischemic left ventricular failure. The present study demon-
strated that myocardial revascularization can currently be
accessible to patients with ICM at a low operative hazard (as
low as 2%) and with a reasonable long-term follow-up.
Assessment of survival estimates after coronary artery
bypass grafting with previously published series presents
some limitations.15 In particular, patient selection principles
are not consistent among the various clinical reports with
regard to the values of left ventricular ejection fraction and the
inclusion of patients with acute myocardial infarction, left
ventricular aneurysm, or valve disease who require surgical
management.5 Despite these limitations, a surgical mortality
rate varying from 2% to 10% has been reported for a consider-
able number of consecutive patients.6,7,14,16,17,19,20,22
Consistent with previously reported actuarial 5-year
survival rates between 64% and 73%,16,17,19,20,22 the long-
term outcomes after myocardial revascularization were also
satisfactory in the present study. Progress in perioperative
management of patients with end-stage ischemic heart
disease6 has been instrumental in transitioning bypass
grafting from a high-risk neglected alternative to trans-
plantation6,7 to a low-risk routine modality. However, the
constant evolution throughout the last decade of time of
patient selection criteria by means of prospective laboratory
investigation and of retrospective risk stratification has
played an even more important role in this transition.6,22
Consequently, reviews of large clinical series, such as the
current one, have been conducted to isolate preoperative
variables that may predict the outcome of revascularization.
Analysis of previous studies shows that a sequence of
patient characteristics, including advanced age, female sex,
lower ejection fraction, comorbid conditions, urgency of
operation, and reoperation, may be linked to increased
operative risk.6,18,24-32 In the present study, both late overall
and late cardiac mortality were associated with lower
ejection fraction, fewer bypass grafts, and longer duration
of cardiopulmonary bypass.
The association between preoperative left ventricular
function and short- and long-term survival is instinctive
because it describes the severity of ischemic left ventricular
failure.14 The number of bypass grafts in the present series
highlights the completeness of the revascularization because
two thirds of patients had two- and three-vessel disease.
Accordingly, the finding of an inverse relationship between
the number of grafts and mortality is consistent with the
results of Luciani and colleagues,3 who reported that
complete myocardial revascularization was inversely linked
to mortality. Complete revascularization of the myocardium
has vast prognostic implications for survival.6 In addition,
the role of the length of cardiopulmonary bypass in
predicting morbi-mortality must also be considered. This
additional aspect emphasizes the magnitude of ischemic
heart disease, where prolonged circulatory assistance may
be mandatory to wean a deteriorating heart from bypass.3
Recently, the Surgical Treatment for Isquemic Heart
Failure (STICH) trial studied surgical ventricular recon-
struction added to CABG in 1,000 patients with heart failure
(LVEF of 35% or less) caused by coronary artery disease.5
The patients were randomly selected to undergo CABG
alone or CABG with surgical ventricular reconstruction; the
median follow-up was 48 months. The findings of this study
showed that adding surgical ventricular reconstruction to
CABG reduced the left ventricular volume compared to
CABG alone. However, this anatomical change was not
associated with a greater improvement in symptoms or
exercise tolerance or with a reduction in the rate of death or
hospitalization for cardiac causes.5
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Limitations. The present study was retrospective and
not randomized, similar to previous studies of myocardial
revascularization in patients with ICM. Modifying medical
practice by increasing the period of cardioplegia, myocar-
dial viability evaluation, and use of the left internal thoracic
artery, might have had an influential role in our findings
unlike previously published work. Late follow-up echo-
cardiographic and coronary angiographic studies were not
executed in all patients. It is difficult to determine if poor
functional outcome is a result of complications related to
myocardial revascularization and/or progressing ICM. This
limitation is present in most of the previously published
papers on this topic. Other colleagues have proposed the
Specific Activity Scale, which has better consistency with
exercise treadmill presentation than NYHA or CCS.3,33
Nevertheless, NYHA and CCS continue to be the main
scoring practices used, and their application is acceptable
if clinical series are to be matched up to. All data were
obtained before 2001, which may modify some results
because of the development of new technologies and
surgical methods after this period.
CONCLUSION
The findings of this study suggest that aneurysmectomy
among patients with severe LV dysfunction results in
short- and long-term favorable outcome function and
survival. In addition to the enduring relief from angina,
most of the patients experienced improvements in con-
gestive heart failure at long-term follow-up. Selection of
appropriate surgical candidates may substantially improve
survival among these patients.
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